We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Abbott Races To Beat Clock In Patent Brawl With Brazil

Law360 (July 7, 2005, 12:00 AM EDT) -- Brazil’s government and Abbott Laboratories are in last-minute talks to avoid a compulsory license on the U.S. drug maker’s AIDS therapy Kaletra, the company said.

Brazil's ministry of health had given Abbott until midnight on Thursday to reduce its prices, but there was no word Friday morning on whether the two partied had been able to come to an agreement.

Abbott presented a new proposal shortly before the government's midnight deadline for agreement, and health ministry officials were said to be studying the company's final offer....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.